Compass PUBLIC | PUBLIC | CMPX Drugging the immune synapse to treat human disease http://www.compasstherapeutics.com Press Releases Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to its Immuno-Oncology Scientific Advisory Board Oct 22, 2019 TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires Sep 3, 2019 Compass Therapeutics Appoints Julie Sunderland to Board of Directors Aug 1, 2019 Compass Therapeutics Announces First Patient Dosed in Phase 1 Trial of CTX-471 Jul 8, 2019 Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471 Jun 17, 2019 COMPASS THERAPEUTICS ANNOUNCES PRECLINICAL DATA ON LEAD ANTIBODY PROGRAM AND NK CELL ENGAGER PLATFORM TO BE PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING Nov 6, 2018 FIERCEBIOTECH NAMES COMPASS THERAPEUTICS A 2018 “FIERCE 15” BIOTECH COMPANY Oct 2, 2018 Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic Jul 12, 2018 Press Coverage FierceBiotech: DDF 2018: How do you fix the glut of immunotherapy combo trials? Oct 5, 2018 FierceBiotech: This year’s Fierce 15 winners on burgeoning biotech investment and the decade ahead Oct 3, 2018 FierceBiotech: FierceBiotech’s 2018 Fierce 15 Oct 2, 2018 Forbes: Four Healthcare Startups Raised Over $130 Million Last Month Aug 6, 2018 BioCentury: COMPASS’ RANGE Aug 3, 2018 Endpoints: Thiel-backed Compass adds $49M to A round, bringing total to $132M Jul 12, 2018 Boston Business Journal: Thiel-backed Cambridge biotech preps launch after closing $170M round Mar 29, 2017 MedCity News: Cambridge-based Compass Therapeutics raising $120M for antibody discovery work Jul 8, 2015
Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to its Immuno-Oncology Scientific Advisory Board Oct 22, 2019
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471 Jun 17, 2019
COMPASS THERAPEUTICS ANNOUNCES PRECLINICAL DATA ON LEAD ANTIBODY PROGRAM AND NK CELL ENGAGER PLATFORM TO BE PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING Nov 6, 2018
Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic Jul 12, 2018
FierceBiotech: This year’s Fierce 15 winners on burgeoning biotech investment and the decade ahead Oct 3, 2018
Boston Business Journal: Thiel-backed Cambridge biotech preps launch after closing $170M round Mar 29, 2017
MedCity News: Cambridge-based Compass Therapeutics raising $120M for antibody discovery work Jul 8, 2015
